Medical Device Design & Development
INDUSTRY PERSPECTIVES
-
What Patients Actually Want From Connected Drug Delivery
A recent survey conducted with BioPhorum members revealed that the most critical aspect of digital healthcare for drug delivery devices. Let's take a closer look.
Where can digital technologies can solve real problems for patients, healthcare providers, and industry, while avoiding unnecessary complexity? Here's where the strongest value propositions currently sit.
An LLM or agentic error can occur with no component broken in any way the QMS recognizes. Classifying it takes two fields: the error type and the error origination point.
We’ve all heard the rhetorical question, “Who owns quality?” And we all reply with the answer they expect to hear: “We all do!” This mindset needs to be fully integrated into the minds and systems of a company.
Engineers with direct exposure to failure outcomes are more likely to build risk mitigation in from the start, not bolt it on later. When they're tapped for leadership positions, this makes them better leaders.
WHITE PAPERS & CASE STUDIES
-
The PMCF Decision Guide
Proposed EU reforms may remove standalone PMCF reporting, yet the duty to proactively collect clinical data remains. Method selection, notified body defense, and data-capture cost determine what comes next.
Quality teams already use general-purpose AI for deviations and submission drafts without validation. Regulators expect governance, and the gap is an undocumented process step, not unreliable output.
Clean audit results confirm past compliance but say little about future performance. As products, markets, and regulations multiply, readiness depends on whether evidence stays connected.
Passing inspections no longer signals that a growth-stage biotech can sustain clinical-stage complexity. The gap between audit readiness and operational readiness opens quietly.
Spreadsheets and siloed quality systems conceal five compounding exposures, from single-person knowledge dependencies to scalability limits, that tend to surface only when an inspector finds them.
MEDICAL DEVICE DESIGN & DEVELOPMENT
Medical device design and development is the cyclical process of creating a device for a specific task or set of tasks, and then continuously reevaluating its effectiveness and improving upon it until the device reaches obsolescence. Design and development begins with ideation and the creation of a concept that, if found to be both fiscally and clinically viable, is then designed, engineered, and prototyped. This preclinical period includes bench testing — accomplished through simulated use of the product — and animal testing, along with any necessary redesign work.
Throughout the process, the proposed medical device, and the process by which it will be manufactured, is examined for flaws that may negatively impact the device’s safety, market viability, regulatory acceptance, customer satisfaction, usability, or profitability. Any shortcomings are corrected, and the improvements applied to the final design. Due to the wireless connectivity capabilities of many modern medical devices, cybersecurity and interoperability also must be incorporated into the design. Clinical testing is conducted, using human subjects, to further expose flaws and confirm product strengths. Once both the product design and the manufacturing process have been validated and approved by the U.S. Food and Drug Administration (FDA), production and commercialization of a device may begin.
LATEST HEADLINES
-
London Biotechnology Show 2026 To Unite Global Life Sciences Leaders, Innovators, Investors10/29/2026
The London Biotechnology Show 2026 will return to ExCeL London on 18–19 November, bringing together biotechnology and pharmaceutical companies, researchers, healthcare professionals, investors, policymakers and technology providers to explore the breakthroughs and commercial opportunities shaping the future of life sciences.
-
Nordson MEDICAL Introduces The New Divert™ ULTRA Line Of Ultra-High- Pressure Stopcocks For Demanding Medical Applications8/19/2026
Nordson MEDICAL introduces Divert™ ULTRA, ultra-high-pressure stopcocks engineered for reliable flow control, ergonomic operation, and precision in demanding medical applications up to 1,500 psi.
-
Discover Medbio's Advanced Manufacturing Solutions For Injectable & Drug Delivery Device5/13/2026
Join Medbio at the Pre-Filled Syringe & Injectable Drug Devices West Coast Summit from June 8th through June 10th, 2026, and visit our team in the trade show exhibition on June 9th and 10th to discover how Medbio supports the evolving needs of injectable drug delivery and combination device manufacturers with precision medical manufacturing solutions.
-
Discover Medbio's Advanced Manufacturing Expertise for Robot-Assisted Surgery At DeviceTalks Boston 20265/12/2026
Visit Medbio at DeviceTalks Boston 2026 to explore scalable manufacturing solutions supporting next-generation robot-assisted surgical systems, precision molding, automation, assembly, and commercialization.
-
Discover Medbio's End-to-End Medical Manufacturing Expertise & Scalability At INTERPHEX 20263/30/2026Visit Medbio at Booth #3912 on April 21st through 23rd at the Javits Center in New York City to discover end-to-end medical manufacturing solutions trusted by over 300 healthcare and medical customers, including the top 30 global medical device and BioPharma manufacturers.
-
Lifecore Biomedical Signs New Agreement With Indomo To Support Innovative Drug/Device Combination Acne Treatment3/4/2026
Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), and Indomo, a clinical-stage company dedicated to expanding access to quality healthcare via innovative device-enabled therapeutics, today announced that the companies have entered into a new development services agreement through which Lifecore will provide Indomo with a range of CDMO services to support the continued development of its corticosteroid drug candidate, DT-001.
-
Strategy Beyond The Bench: Eurofins Launches New U.S. Consulting Chapter In Medtech Strategy & Policy2/19/2026
In launching this key offering, Eurofins Medical Device Consulting marks an inflection point for its Medical Device, Combination Product, and Diagnostic service portfolio – moving from testing services provider to full-lifecycle partner in strategy and insights.
-
Accumold Makes Pharmapack Europe Debut To Support Next-Generation Drug Delivery And Pharma Packaging1/15/2026
See how precision micro molding enables scalable, reliable drug delivery and pharmaceutical packaging designs as industry experts debut at Pharmapack Europe 2026 in Paris, January 21–22.